Cullinan Therapeutics, Inc. (CGEM)
NASDAQ · Healthcare
Cullinan Therapeutics, Inc. Cash Flow 2020–2022
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -175.8M | -145.3M | -134.3M | -126.7M | -43.4M | -29.8M |
| Depreciation & Amort. | 311,000 | 306,000 | 310,000 | 93,000 | 53,000 | 62,000 |
| Investing Activities | ||||||
| Capital Expenditure | 49,000 | 0 | 208,000 | 1.1M | 0 | 10,000 |
| Free Cash Flow | -175.8M | -145.3M | -134.5M | -127.8M | -43.4M | -29.8M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | 6.6M |
Cullinan Therapeutics, Inc. Cash Flow — FAQ
Cullinan Therapeutics, Inc. (CGEM) cash flow over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CGEM's cash flow history?
The chart and table above show Cullinan Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.